Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Iscience|January 14, 2026
A gene-expression module identifies circulating immune cells with enhanced recruitment to sites of inflammationDebajyoti Sinha, Thomas Laurent, Alexis Broquet, et al.
Clinical Immunology (Orlando, Fla.)|April 7, 2016
Neuropathologic, phenotypic and functional analyses of Mucosal Associated Invariant T cells in Multiple SclerosisMarion Salou, Bryan Nicol, Alexandra Garcia, et al.
Plos One|January 4, 2014
Characterization of antigen-specific B cells using nominal antigen-coated flow-beadsNicolas Degauque, Annie Elong Ngono, Annie Elong Ngono, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2019
Cytotoxic CD8+ T lymphocytes expressing ALS-causing SOD1 mutant selectively trigger death of spinal motoneuronsEmmanuelle Coque, Céline Salsac, Gabriel Espinosa-Carrasco, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 21, 2015
Peripheral phenotype and gene expression profiles of combined liver-kidney transplant patientsErwan Dumontet, Richard Danger, Parsia A Vagefi, et al.
Nature Communications|October 28, 2018
IL-7 receptor blockade blunts antigen-specific memory T cell responses and chronic inflammation in primatesLyssia Belarif, Caroline Mary, Lola Jacquemont, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 25, 2018
High circulating CD4+CD25hiFOXP3+ T-cell sub-population early after lung transplantation is associated with development of bronchiolitis obliterans syndromeMaxim Durand, Philippe Lacoste, Richard Danger, et al.
Journal of Autoimmunity|October 22, 2017
An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8+ T cells involved in multiple sclerosisBryan Nicol, Marion Salou, Isabel Vogel, et al.
Trials|March 22, 2021
Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trialBenjamin Gaborit, Bernard Vanhove, Marie-Anne Vibet, et al.
Journal of the American Society of Nephrology : JASN|October 24, 2022
Effector Memory-Expressing CD45RA (TEMRA) CD8+ T Cells from Kidney Transplant Recipients Exhibit Enhanced Purinergic P2X4 Receptor-Dependent Proinflammatory and Migratory ResponsesTra-My Doan Ngoc, Gaëlle Tilly, Richard Danger, et al.
Pageof 9